News

FDA Upheaval Pushes Some Biotech Firms to Plan Early Trials Out of US
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...
Upheaval at FDA pushes some biotech firms to move early trials out of US
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
European governments scramble to interpret Trump's new drug pricing order
European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...
The Manila Times16h
Zevra Reports First Quarter 2025 Financial Results and Corporate Update
OLPRUVA: 5 new patient enrollment forms were received in Q1 2025, bringing the total from initial product availability in July 2023, and including Zevra's promotion of OLPRUVA since late January 2024, ...
Aurobindo Pharma arm’s biosimilar gets marketing nod from U.K.’s MHRA
Aurobindo Pharma's CuraTeQ Biologics receives marketing authorization for Zefylti filgrastim biosimilar in the UK and EU.